Bronchopulmonary aspergillosis – Life with Disease

Go back

Bronchopulmonary aspergillosis is a lung condition that develops when a person’s immune system reacts strongly to a common fungus found in soil and decaying plants. For people with asthma or cystic fibrosis, this reaction can lead to persistent inflammation in the airways, causing symptoms that go beyond typical breathing difficulties and requiring specialized treatment to protect the lungs from long-term damage.

Understanding the Outlook for People With Bronchopulmonary Aspergillosis

When someone receives a diagnosis of allergic bronchopulmonary aspergillosis, or ABPA, it is natural to feel concerned about what the future holds. Understanding the prognosis can help patients and their loved ones prepare for the journey ahead with realistic expectations and hope.[1]

The outlook for people with ABPA varies widely depending on how early the condition is detected and how well it responds to treatment. Many people who receive prompt diagnosis and appropriate medical care can achieve remission, a state where symptoms settle, inflammation subsides, and blood markers return to more normal levels. During remission, individuals often experience no symptoms related to ABPA, their underlying asthma becomes easier to control, and chest imaging shows no new concerning changes.[18]

However, ABPA is considered a long-term condition that requires ongoing monitoring. Some people experience relapses, meaning that after a period of remission, symptoms can return. These flare-ups may happen months or even years after the initial diagnosis. With each relapse, treatment typically involves restarting or adjusting medications to bring inflammation back under control.[12]

A smaller number of people may progress to what doctors call end-stage ABPA. At this point, the disease has caused extensive bronchiectasis, which is abnormal widening of the airways, and fibrosis, which means scarring of the lung tissue. People at this stage may experience more persistent breathing problems and become more vulnerable to lung infections. Their response to steroid treatment may be less effective than it was earlier in the disease.[13]

⚠️ Important
Even in advanced stages, ABPA is not considered a death sentence. Many people live for years with stable symptoms, managing their condition through ongoing medical care. The key is early detection and consistent treatment to slow or prevent the progression of lung damage.

It is worth noting that the survival outlook depends heavily on individual factors such as the person’s overall health, how well their immune system functions, and whether the fungus causing the reaction shows resistance to antifungal treatments. People who also have other serious lung conditions may face more complications, but with careful management, quality of life can still be maintained.[13]

How Bronchopulmonary Aspergillosis Progresses Without Treatment

Without proper treatment, allergic bronchopulmonary aspergillosis can follow a predictable but damaging path. The disease develops because the fungus called Aspergillus fumigatus settles into the airways of people who already have conditions like asthma or cystic fibrosis. The thick mucus in their airways makes it difficult for the body to clear out the fungal spores once they are breathed in.[1]

When the immune system recognizes the fungus, it launches an aggressive response, treating the harmless spores as if they are dangerous invaders. This overreaction causes repeated episodes of inflammation in the airways. Over weeks and months, the inflammation creates an environment where mucus builds up, airways become obstructed, and the lungs cannot function as efficiently as they should.[12]

As time goes on, the constant inflammation and immune activity begin to damage the structure of the airways themselves. The bronchial tubes start to widen abnormally, a condition called bronchiectasis. Once this happens, the airways lose their ability to clear mucus and debris effectively. This creates a cycle where infections become more frequent, further worsening lung function.[6]

In addition to bronchiectasis, untreated ABPA can lead to fibrosis, where healthy, flexible lung tissue is replaced by stiff, scarred tissue. This scarring reduces the lungs’ capacity to expand and contract, making breathing increasingly difficult. Over time, this can result in pulmonary hypertension, a condition where the blood pressure in the lungs becomes dangerously high, and eventually respiratory failure, where the lungs can no longer supply the body with enough oxygen.[13]

Without intervention, the disease also increases the risk of developing other forms of aspergillosis. In rare cases, particularly when there are cavities or hollow spaces in the lungs from previous damage, the fungus can form tangled masses called aspergillomas. These fungal balls can cause coughing up of blood and other serious complications.[3]

Possible Complications That Can Arise

Even with treatment, allergic bronchopulmonary aspergillosis can lead to unexpected and concerning complications. Recognizing these early and addressing them with medical care is essential to maintaining lung health and overall wellbeing.[1]

One of the more alarming complications is hemoptysis, which is the medical term for coughing up blood. This happens because the inflamed and irritated airways can become fragile and start to bleed. People with ABPA may notice brown-colored mucus or even bright red blood in their sputum. While small amounts of blood-streaked mucus may not be immediately dangerous, larger amounts of bleeding require urgent medical attention.[19]

Bronchiectasis is another major complication. As mentioned earlier, this is the permanent widening and damage of the airways. Once bronchiectasis develops, it cannot be reversed. It makes the lungs more prone to bacterial infections such as pneumonia, which can further damage the lungs and require repeated courses of antibiotics.[13]

Some people with ABPA develop atelectasis, which occurs when part of the lung collapses because the airways become blocked by thick mucus plugs. This can cause sudden shortness of breath and chest pain. If not treated promptly, it can lead to lower oxygen levels in the blood and the need for hospitalization.[19]

In rare situations, the immune system’s ongoing fight against the fungus can cause the disease to spread beyond the lungs. Though ABPA primarily affects the respiratory system, some individuals may develop allergic fungal sinusitis, where the sinuses become inflamed and filled with thick mucus and fungal material. This condition often requires surgical intervention in addition to medication.[11]

Long-term steroid use, which is a cornerstone of ABPA treatment, comes with its own set of complications. Over months and years, steroids can lead to weakened bones, weight gain, high blood sugar, increased risk of infections, and mood changes. Balancing the need for steroids to control inflammation with the side effects they cause is a constant challenge in managing ABPA.[2]

How Bronchopulmonary Aspergillosis Affects Daily Life

Living with allergic bronchopulmonary aspergillosis can touch nearly every aspect of a person’s day-to-day experience. The physical symptoms, the emotional weight of managing a chronic illness, and the need to adjust routines all shape the reality of life with this condition.[14]

From a physical standpoint, the hallmark symptoms of ABPA—wheezing, shortness of breath, and persistent coughing—can make even simple tasks feel exhausting. Activities that most people take for granted, such as climbing stairs, carrying groceries, or playing with children, may become difficult or impossible during flare-ups. People often describe feeling as though they cannot get enough air, which can be frightening and frustrating.[2]

The need to cough up thick, brown mucus plugs is not only uncomfortable but can also be embarrassing in social situations. Some people find themselves avoiding public places or social gatherings because they worry about having a coughing fit or needing to clear their airways frequently.[14]

Work life can be significantly impacted as well. Frequent medical appointments, hospital visits for flare-ups, and the side effects of medications can lead to missed workdays. For those whose jobs involve physical labor or exposure to dust, mold, or outdoor environments, it may become necessary to change careers or request workplace accommodations. Self-employment or flexible work arrangements may become more practical options.[14]

Hobbies and activities that involve physical exertion, such as sports or hiking, may need to be modified or given up entirely. For musicians, singers, or anyone whose passion involves breath control, ABPA can feel like a loss of identity. However, some people find that singing or playing wind instruments, when done carefully and with medical guidance, can actually help improve breathing.[14]

The emotional and mental health impact of ABPA should not be underestimated. Living with a chronic, unpredictable illness can lead to anxiety, depression, and a sense of isolation. The fear of relapse, the frustration of managing symptoms, and the uncertainty about the future can weigh heavily on patients. It is common for people to feel overwhelmed by the complexity of their treatment regimen and the need to constantly monitor their health.[13]

⚠️ Important
Connecting with others who have ABPA, whether through support groups or online communities, can provide emotional relief and practical advice. Sharing experiences with people who understand the challenges can reduce feelings of isolation and help individuals feel more empowered in managing their condition.

Family relationships can also be affected. Loved ones may struggle to understand what the person with ABPA is going through, especially if symptoms are not visible from the outside. Patients may feel guilty about needing help or being unable to participate in family activities. Open communication and education about the disease can help bridge this gap and foster a supportive home environment.[14]

Sleep can become disrupted due to nighttime coughing, breathing difficulties, or the side effects of medications. Poor sleep further contributes to fatigue, making it harder to cope with daily demands. Strategies such as elevating the head of the bed, using humidifiers, and practicing good sleep hygiene can help improve rest.[4]

Support for Families Considering Clinical Trials

For families navigating allergic bronchopulmonary aspergillosis, clinical trials can represent an opportunity to access new treatments and contribute to advancing medical knowledge. However, the decision to participate in a trial is complex and should be made with careful consideration and full understanding of what is involved.[13]

Clinical trials are research studies that test new medications, therapies, or diagnostic tools to determine if they are safe and effective. For ABPA, trials may focus on new antifungal drugs, biologic therapies that target specific parts of the immune system, or improved ways to monitor disease activity. Participation in a trial may give patients access to treatments that are not yet available to the general public.[13]

Family members can play a crucial role in helping their loved one decide whether to join a clinical trial. The first step is to have an open conversation with the patient’s healthcare team. Doctors can explain whether there are any ongoing trials that might be suitable based on the patient’s specific situation, disease stage, and overall health. Not every person with ABPA will be eligible for every trial, as studies often have strict criteria about who can participate.[13]

It is important for families to ask detailed questions about the trial before agreeing to participate. What is the purpose of the study? What are the potential benefits and risks? Will the patient receive a placebo, or will they definitely receive the experimental treatment? How often will appointments be required, and will there be any costs involved? Understanding the answers to these questions helps ensure that everyone is making an informed decision.[13]

Relatives can assist with practical aspects of trial participation, such as keeping track of appointment schedules, helping with transportation to study visits, and maintaining records of symptoms and side effects. Clinical trials often require frequent monitoring and detailed documentation, which can be time-consuming and overwhelming for the patient alone.[13]

Emotional support is equally important. Participating in a trial can bring hope, but it can also bring uncertainty and anxiety. Family members can provide reassurance, accompany the patient to appointments, and help them process information and decisions. It is also essential for families to respect the patient’s autonomy and ensure that the decision to participate is truly the patient’s choice, not influenced by pressure from others.[13]

Families should be aware that participation in a clinical trial is always voluntary, and patients can withdraw at any time without it affecting their regular medical care. If at any point the trial becomes too burdensome or the patient has concerns about safety, they have the right to stop participating.[13]

Finally, families can help by learning about where to find information about clinical trials. Websites such as those maintained by national health organizations or research centers often list ongoing studies. Healthcare providers can also provide guidance on how to search for trials that may be appropriate. Being proactive in seeking out these opportunities can open doors to new options for managing ABPA.[13]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Corticosteroids (e.g., Prednisone) – Oral steroids used to reduce inflammation in the airways and control allergic reactions in ABPA. They are the primary treatment for managing this condition.
  • Itraconazole – An oral antifungal medication that may be used alongside corticosteroids to reduce the fungal burden and help prevent relapses in ABPA.
  • Voriconazole – Another antifungal agent used in certain aspergillosis cases, particularly when itraconazole is not suitable or effective.
  • Omalizumab (Xolair) – A monoclonal antibody that targets IgE, used in some cases of ABPA to reduce allergic inflammation and may help patients reduce steroid use.
  • Dupilumab – A biologic therapy that is being evaluated for use in ABPA to target specific immune pathways involved in allergic inflammation.

Ongoing Clinical Trials on Bronchopulmonary aspergillosis

  • Study of inhaled liposomal amphotericin B and technetium-99m to assess lung distribution in patients with chronic pulmonary aspergillosis

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

References

https://www.ncbi.nlm.nih.gov/books/NBK542329/

https://www.aaaai.org/conditions-treatments/related-conditions/allergic-bronchopulmonary-aspergillosis

https://www.mayoclinic.org/diseases-conditions/aspergillosis/symptoms-causes/syc-20369619

https://aafa.org/asthma/asthma-triggers-causes/health-conditions-that-trigger-asthma/allergic-bronchopulmonary-aspergillosis/

https://allergyasthmanetwork.org/news/allergic-bronchopulmonary-aspergillosis-abpa/

https://www.nationaljewish.org/conditions/abpa

https://www.columbiadoctors.org/childrens-health/pediatric-specialties/allergy/treatments-conditions/allergic-bronchopulmonary-aspergillosis-abpa

https://www.ncbi.nlm.nih.gov/books/NBK542329/

https://www.mayoclinic.org/diseases-conditions/aspergillosis/diagnosis-treatment/drc-20369623

https://allergyasthmanetwork.org/news/allergic-bronchopulmonary-aspergillosis-abpa/

https://emedicine.medscape.com/article/296052-treatment

https://www.merckmanuals.com/professional/pulmonary-disorders/asthma-and-related-disorders/allergic-bronchopulmonary-aspergillosis-abpa

https://fightfungus.org/living-with-aspergillosis/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6544785/

https://allergyasthmanetwork.org/news/allergic-bronchopulmonary-aspergillosis-abpa/

https://www.cdc.gov/aspergillosis/prevention/index.html

https://www.lung.org/lung-health-diseases/lung-disease-lookup/aspergillosis/treatment

https://aspergillosis.org/understanding-abpa-a-patient-guide-to-managing-allergic-bronchopulmonary-aspergillosis/

https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/aspergillus

FAQ

Can allergic bronchopulmonary aspergillosis be cured?

ABPA cannot be completely cured, but it can go into remission with proper treatment. During remission, symptoms disappear, asthma is well-controlled, and there are no new signs of the disease on imaging tests. However, relapses can occur, requiring ongoing monitoring and treatment adjustments.

Is ABPA contagious?

No, ABPA is not contagious. It cannot spread from person to person or from animals to people. It is an allergic reaction that occurs in certain individuals when their immune system overreacts to Aspergillus fungus spores that they breathe in from the environment.

How is ABPA different from regular asthma?

While ABPA primarily affects people with asthma, it involves a specific allergic reaction to Aspergillus fungus that causes more severe and persistent inflammation. Unlike regular asthma, ABPA can lead to permanent lung damage such as bronchiectasis and fibrosis if not treated early.

What should I avoid if I have ABPA?

People with ABPA should try to avoid dusty areas, construction sites, compost heaps, and environments with visible mold. Wearing an N95 respirator mask in unavoidable dusty settings and keeping indoor spaces dry and well-ventilated can help reduce exposure to Aspergillus spores.

Do I need to take steroids forever?

Not necessarily. The duration of steroid treatment depends on how well the disease responds and whether you achieve remission. Some people require steroids only during flare-ups, while others with more severe or chronic ABPA may need long-term, lower-dose maintenance therapy. Your doctor will tailor the treatment to your individual needs.

🎯 Key takeaways

  • ABPA is a manageable condition with early treatment, and many people achieve remission where symptoms disappear and lung function stabilizes.
  • The disease is caused by an overreaction of the immune system to a common environmental fungus, not by an infection that spreads from person to person.
  • Without treatment, ABPA can cause permanent lung damage including bronchiectasis and fibrosis, but this can be prevented with appropriate medical care.
  • Living with ABPA can affect physical abilities, work, hobbies, and emotional wellbeing, but support networks and treatment adjustments can greatly improve quality of life.
  • Steroids remain the main treatment, but antifungal drugs and newer biologic therapies are also used to reduce inflammation and prevent relapses.
  • Families play a critical role in supporting patients, especially when considering participation in clinical trials that may offer access to cutting-edge treatments.
  • Avoiding dusty and moldy environments, wearing protective masks, and keeping homes dry can help reduce exposure to Aspergillus spores.
  • Genetic factors may influence who develops ABPA, with certain immune system markers making some people more susceptible than others.